PMA

P880031: VITRAX SODIUM HYALURONATE

FDA PMA · AID, SURGICAL, VISCOELASTIC · Abbott Medical Optics, Inc.

Key facts

PMA number P880031
Trade name VITRAX SODIUM HYALURONATE
Generic name AID, SURGICAL, VISCOELASTIC
Applicant Abbott Medical Optics, Inc.
Owner/operator ABBOTT LABORATORIES
Product code LZP
Approval date Aug 10, 1989
Docket number 89M-0344
Notice date Sep 13, 1989
Establishment registration 3004936110
FEI number 3004936110

At a glance

  • 10–99 Supplements
  • Feb 18, 2009 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals